Study M23-324: A First-in-Human Study of ABBV-525 (MALT1 inhibitor) in B cell malignancies

  • Si Lun Tam, Con (Primary Chief Investigator (PCI))
  • Malherbe, Maturos (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date27/09/23 → 26/09/25

Keywords

  • Clinical trial
  • M23-324